a developer of the INTERCEPT Blood System for platelets and plasma
Industry MedicalSpecialties
A.I.dvisor indicates that over the last year, CERS has been loosely correlated with MASS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then MASS could also see price increases.
Ticker / NAME | Correlation To CERS | 1D Price Change % | ||
---|---|---|---|---|
CERS | 100% | -1.59% | ||
MASS - CERS | 50% Loosely correlated | -19.86% | ||
FLGT - CERS | 44% Loosely correlated | -3.86% | ||
ICUI - CERS | 44% Loosely correlated | -1.80% | ||
BNGO - CERS | 43% Loosely correlated | +4.53% | ||
CRL - CERS | 41% Loosely correlated | -4.35% | ||
More |
Ticker / NAME | Correlation To CERS | 1D Price Change % |
---|---|---|
CERS | 100% | -1.59% |
medical research theme (126 stocks) | 44% Loosely correlated | -2.00% |
medical service theme (154 stocks) | 41% Loosely correlated | -2.06% |
plasma-based theme (2 stocks) | 34% Loosely correlated | +0.89% |
Medical Specialties theme (428 stocks) | 32% Poorly correlated | -1.28% |
Medical Specialties theme (418 stocks) | 32% Poorly correlated | -1.48% |
More |